AI Summary

Radiopharmaceutical therapy (RPT) has made significant strides over the past 50 years, although it only recently received FDA approval to treat prostate cancer. But despite the progress—and billions of dollars in industry investments—one area that has lagged behind is dosing, which is still one-size-fits-all. Now, researchers at the University of Massachuse…

AI summaries can be wrong sometimes—always verify important details using the source article.